Search research articles
Contact Us
Filters
Showing results (11-20 of 67) with videos related to
Page
of 7
Sort By:
Anti-Cancer Agents in Medicinal Chemistry
|
May 21, 2015
Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities
Maria de Fatima Pereira, Christophe Rochais, Patrick Dallemagne
Future Medicinal Chemistry
|
May 16, 2017
Modulating 5-HT<sub>4</sub> and 5-HT<sub>6</sub> receptors in Alzheimer's disease treatment
Julien Lalut, Delphine Karila, Patrick Dallemagne, et al.
Pharmaceutics
|
October 28, 2023
Conceptual Framework of the Design of Pleiotropic Drugs against Alzheimer's Disease
Thomas Guiselin, Cédric Lecoutey, Christophe Rochais, et al.
The Journal of Pharmacy and Pharmacology
|
April 18, 2020
Drug repositioning: a brief overview
Jean-Pierre Jourdan, Ronan Bureau, Christophe Rochais, et al.
Journal of Medicinal Chemistry
|
May 28, 2020
Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges
Pauline Zipfel, Christophe Rochais, Kévin Baranger, et al.
Expert Opinion on Therapeutic Patents
|
May 14, 2020
Therapeutic modulators of the serotonin 5-HT<sub>4</sub> receptor: a patent review (2014-present)
Caroline Lanthier, Patrick Dallemagne, Cédric Lecoutey, et al.
Bioorganic & Medicinal Chemistry
|
October 14, 2009
Synthesis, reactivity and biological evaluation of novel halogenated tripentones
Vittoria Perri, Christophe Rochais, Thierry Cresteil, et al.
Expert Opinion on Drug Discovery
|
January 28, 2022
Advances in prodrug design for Alzheimer's disease: the state of the art
Valentin Travers-Lesage, Serge M Mignani, Patrick Dallemagne, et al.
Molecular Informatics
|
April 15, 2024
Discovery of a pocket network on the domain 5 of the TrkB receptor - A potential new target in the quest for the new ligands
Mirjana Antonijevic, Jana Sopkova-de Oliveira Santos, Patrick Dallemagne, et al.
European Journal of Medicinal Chemistry
|
April 14, 2020
hERG toxicity assessment: Useful guidelines for drug design
Amanda Garrido, Alban Lepailleur, Serge M Mignani, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 67) with videos related to
Sort By:
Page
of 7
Anti-Cancer Agents in Medicinal Chemistry
|
May 21, 2015
Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities
Maria de Fatima Pereira, Christophe Rochais, Patrick Dallemagne
Future Medicinal Chemistry
|
May 16, 2017
Modulating 5-HT<sub>4</sub> and 5-HT<sub>6</sub> receptors in Alzheimer's disease treatment
Julien Lalut, Delphine Karila, Patrick Dallemagne, et al.
Pharmaceutics
|
October 28, 2023
Conceptual Framework of the Design of Pleiotropic Drugs against Alzheimer's Disease
Thomas Guiselin, Cédric Lecoutey, Christophe Rochais, et al.
The Journal of Pharmacy and Pharmacology
|
April 18, 2020
Drug repositioning: a brief overview
Jean-Pierre Jourdan, Ronan Bureau, Christophe Rochais, et al.
Journal of Medicinal Chemistry
|
May 28, 2020
Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges
Pauline Zipfel, Christophe Rochais, Kévin Baranger, et al.
Expert Opinion on Therapeutic Patents
|
May 14, 2020
Therapeutic modulators of the serotonin 5-HT<sub>4</sub> receptor: a patent review (2014-present)
Caroline Lanthier, Patrick Dallemagne, Cédric Lecoutey, et al.
Bioorganic & Medicinal Chemistry
|
October 14, 2009
Synthesis, reactivity and biological evaluation of novel halogenated tripentones
Vittoria Perri, Christophe Rochais, Thierry Cresteil, et al.
Expert Opinion on Drug Discovery
|
January 28, 2022
Advances in prodrug design for Alzheimer's disease: the state of the art
Valentin Travers-Lesage, Serge M Mignani, Patrick Dallemagne, et al.
Molecular Informatics
|
April 15, 2024
Discovery of a pocket network on the domain 5 of the TrkB receptor - A potential new target in the quest for the new ligands
Mirjana Antonijevic, Jana Sopkova-de Oliveira Santos, Patrick Dallemagne, et al.
European Journal of Medicinal Chemistry
|
April 14, 2020
hERG toxicity assessment: Useful guidelines for drug design
Amanda Garrido, Alban Lepailleur, Serge M Mignani, et al.
Page
of 7